Foyston, Gordon, & Payne’s CME Group CME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $4.27M | Sell |
14,450
-31
| -0.2% | -$9.21K | 0.98% | 37 |
|
|
2025
Q4 | $3.95M | Sell |
14,481
-326
| -2% | -$88.6K | 0.86% | 36 |
|
|
2025
Q3 | $4M | Sell |
14,807
-587
| -4% | -$160K | 0.87% | 36 |
|
|
2025
Q2 | $4.24M | Buy |
15,394
+158
| +1% | +$43K | 0.97% | 32 |
|
|
2025
Q1 | $4.04M | Buy |
15,236
+143
| +0.9% | +$35.3K | 1% | 32 |
|
|
2024
Q4 | $3.51M | Buy |
15,093
+15
| +0.1% | +$3.45K | 0.93% | 33 |
|
|
2024
Q3 | $3.33M | Sell |
15,078
-7,038
| -32% | -$1.46M | 0.83% | 37 |
|
|
2024
Q2 | $4.35M | Sell |
22,116
-300
| -1% | -$62K | 1.07% | 33 |
|
|
2024
Q1 | $4.83M | Buy |
22,416
+3,786
| +20% | +$795K | 1.16% | 35 |
|
|
2023
Q4 | $3.92M | Buy |
18,630
+462
| +3% | +$98.6K | 0.99% | 40 |
|
|
2023
Q3 | $3.64M | Buy |
18,168
+5,319
| +41% | +$1.06M | 0.99% | 38 |
|
|
2023
Q2 | $2.38M | Sell |
12,849
-358
| -3% | -$66.2K | 0.62% | 42 |
|
|
2023
Q1 | $2.53M | Sell |
13,207
-6,713
| -34% | -$1.21M | 0.68% | 43 |
|
|
2022
Q4 | $3.35M | Sell |
19,920
-5,575
| -22% | -$969K | 0.93% | 41 |
|
|
2022
Q3 | $4.52M | Buy |
25,495
+11,952
| +88% | +$2.36M | 1.24% | 30 |
|
|
2022
Q2 | $4.09M | Sell |
13,543
-6,740
| -33% | -$1.43M | 1.18% | 33 |
|
|
2022
Q1 | $4.83M | Buy |
20,283
+1,345
| +7% | +$316K | 1.18% | 31 |
|
|
2021
Q4 | $4.33M | Sell |
18,938
-279
| -1% | -$61.4K | 1.01% | 37 |
|
|
2021
Q3 | $3.72M | Buy |
19,217
+120
| +0.6% | +$24.3K | 0.93% | 36 |
|
|
2021
Q2 | $4.06M | Sell |
19,097
-2,080
| -10% | -$439K | 0.97% | 35 |
|
|
2021
Q1 | $4.33M | Sell |
21,177
-1,006
| -5% | -$198K | 1.02% | 34 |
|
|
2020
Q4 | $4.04M | Sell |
22,183
-1,534
| -6% | -$261K | 0.97% | 37 |
|
|
2020
Q3 | $3.97M | Buy |
+23,717
| New | +$3.99M | 1.02% | 33 |
|
Other funds holding CME
VCM
VPM
